EWTX Edgewise Therapeutics, Inc.
Nasdaq · SEC CIK 1710072 · EDGAR
- Bought, last 12 months
- $199.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $19.50M 12 sales by 6 insiders
- Filings on record
- 171 since 2021-08-19, latest 2026-08-17 18:41
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Russell Alan J | CSO, Dir | — | $10.25M |
| Donovan Joanne M. | CMO | — | $4.62M |
| Edris Badreddin | Dir | — | $3.40M |
| KOCH KEVIN | Pres, CEO, Dir | — | $785.0K |
| Derakhshan Behrad | Chief Business Off | — | $223.4K |
| MOORE JOHN R | GC | — | $219.8K |
| Fox Jonathan C | Dir | $199.4K | — |
Transactions 157
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-01-25 | 2024-01-23 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $11.00 | +454.5K | 14.44M | +3% | +$5.00M |
| I | 2024-01-25 | 2024-01-23 | EWTX | OrbiMed Capital GP VI LLC | Dir, 10% | P - Purchase | $11.00 | +454.5K | 14.44M | +3% | +$5.00M |
| DT | 2024-01-25 | 2024-01-23 | EWTX | Carruthers R Michael | CFO | M - OptEx | $1.93 | +90.0K | 119.0K | +310% | +$173.7K |
| DT | 2024-01-25 | 2024-01-23 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $15.78 | -90.0K | 29.0K | -76% | -$1.42M |
| 2023-12-28 | 2023-12-26 | EWTX | Fox Jonathan C | Dir | P - Purchase | $9.30 | +10.9K | 10.9K | New | +$101.0K | |
| 2023-12-28 | 2023-12-27 | EWTX | MOORE JOHN R | GC | S - Sale | $10.50 | -8,497 | 0 | -100% | -$89.2K | |
| 2023-12-28 | 2023-12-26 | EWTX | Russell Alan J | CSO, Dir | S - Sale | $9.33 | -172.6K | 3,606 | -98% | -$1.61M | |
| D | 2023-06-26 | 2023-06-22 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.71 | +10.0K | 29.0K | +53% | +$7,100 |
| D | 2023-05-03 | 2023-05-01 | EWTX | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | +5,208 | 177.8K | +3% | $0 |
| D | 2023-05-03 | 2023-05-02 | EWTX | Russell Alan J | CSO, Dir | S - Sale+OE | $8.90 | -1,602 | 176.2K | -0.9% | -$14.3K |
| D | 2023-05-03 | 2023-05-01 | EWTX | MOORE JOHN R | GC | M - OptEx | $0.00 | +5,208 | 8,462 | +160% | $0 |
| D | 2023-05-03 | 2023-05-02 | EWTX | MOORE JOHN R | GC | S - Sale+OE | $8.90 | -1,897 | 6,565 | -22% | -$16.9K |
| D | 2023-05-03 | 2023-05-01 | EWTX | Donovan Joanne M. | CMO | M - OptEx | $0.00 | +10.4K | 13.2K | +372% | $0 |
| D | 2023-05-03 | 2023-05-02 | EWTX | Donovan Joanne M. | CMO | S - Sale+OE | $8.90 | -3,254 | 9,960 | -25% | -$29.0K |
| D | 2023-05-03 | 2023-05-02 | EWTX | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $8.90 | -1,747 | 7,020 | -20% | -$15.5K |
| D | 2023-05-03 | 2023-05-01 | EWTX | Derakhshan Behrad | Chief Business Off | M - OptEx | $0.00 | +5,208 | 8,767 | +146% | $0 |
| D | 2023-05-03 | 2023-05-01 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.00 | +5,208 | 17.5K | +43% | $0 |
| D | 2023-05-03 | 2023-05-02 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $8.90 | -1,336 | 16.1K | -8% | -$11.9K |
| D | 2023-05-03 | 2023-05-02 | EWTX | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $8.90 | -3,203 | 7,213 | -31% | -$28.5K |
| D | 2023-05-03 | 2023-05-01 | EWTX | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | +10.4K | 10.4K | New | $0 |
| D | 2022-10-05 | 2022-10-03 | EWTX | MOORE JOHN R | GC | S - Sale+OE | $9.76 | -4,730 | 3,000 | -61% | -$46.2K |
| D | 2022-10-05 | 2022-10-03 | EWTX | MOORE JOHN R | GC | M - OptEx | $1.93 | +4,730 | 7,730 | +158% | +$9,129 |
| I | 2022-09-16 | 2022-09-16 | EWTX | OrbiMed Genesis GP LLC | Dir, 10% | P - Purchase | $10.32 | +484.5K | 13.98M | +4% | +$5.00M |
| 2022-09-16 | 2022-09-14 | EWTX | Novo Holdings A/S | 10% | P - Purchase | $10.32 | +484.5K | 6.07M | +9% | +$5.00M | |
| I | 2022-09-16 | 2022-09-16 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $10.32 | +484.5K | 13.98M | +4% | +$5.00M |
| D | 2022-09-08 | 2022-09-06 | EWTX | MOORE JOHN R | GC | M - OptEx | $1.93 | +4,730 | 7,730 | +158% | +$9,129 |
| DM | 2022-09-08 | 2022-09-06 | EWTX | MOORE JOHN R | GC | S - Sale+OE | $10.91 | -4,730 | 3,000 | -61% | -$51.6K |
| DM | 2022-08-05 | 2022-08-03 | EWTX | MOORE JOHN R | GC | M - OptEx | $1.34 | +9,232 | 7,730 | New | +$12.3K |
| D | 2022-08-05 | 2022-08-03 | EWTX | MOORE JOHN R | GC | S - Sale+OE | $9.31 | -9,232 | 3,000 | -75% | -$85.9K |
| DM | 2022-07-07 | 2022-07-05+ | EWTX | MOORE JOHN R | GC | S - Sale+OE | $8.37 | -9,232 | 3,000 | -75% | -$77.3K |
| DM | 2022-07-07 | 2022-07-05+ | EWTX | MOORE JOHN R | GC | M - OptEx | $1.34 | +9,232 | 4,046 | New | +$12.3K |
| DM | 2022-06-21 | 2022-06-16+ | EWTX | MOORE JOHN R | GC | M - OptEx | $1.69 | +67.9K | 16.5K | New | +$114.6K |
| DM | 2022-06-21 | 2022-06-16+ | EWTX | MOORE JOHN R | GC | S - Sale+OE | $6.83 | -67.9K | 3,000 | -96% | -$463.9K |
| DM | 2022-06-15 | 2022-06-13+ | EWTX | MOORE JOHN R | GC | M - OptEx | $0.7371 | +26.4K | 21.7K | New | +$19.4K |
| DM | 2022-06-15 | 2022-06-13+ | EWTX | MOORE JOHN R | GC | S - Sale+OE | $6.08 | -26.4K | 3,000 | -90% | -$160.5K |
| DM | 2022-06-10 | 2022-06-08+ | EWTX | MOORE JOHN R | GC | M - OptEx | $0.71 | +27.3K | 10.6K | New | +$19.4K |
| DM | 2022-06-10 | 2022-06-08+ | EWTX | MOORE JOHN R | GC | S - Sale+OE | $6.44 | -27.3K | 3,000 | -90% | -$175.8K |
| DM | 2022-06-07 | 2022-06-03+ | EWTX | MOORE JOHN R | GC | S - Sale+OE | $6.26 | -47.3K | 3,000 | -94% | -$296.0K |
| DM | 2022-06-07 | 2022-06-03+ | EWTX | MOORE JOHN R | GC | M - OptEx | $1.49 | +47.3K | 16.9K | New | +$70.3K |
| D | 2022-05-25 | 2022-05-23 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.71 | +9,000 | 12.0K | +300% | +$6,390 |
| I | 2022-05-20 | 2022-05-18 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $7.21 | +138.0K | 13.50M | +1% | +$995.0K |
| I | 2022-05-20 | 2022-05-18 | EWTX | OrbiMed Capital GP VI LLC | Dir, 10% | P - Purchase | $7.21 | +138.0K | 13.50M | +1% | +$995.0K |
| 2022-05-18 | 2022-05-16 | EWTX | MOORE JOHN R | GC | S - Sale | $7.42 | -10.8K | 3,000 | -78% | -$80.1K | |
| I | 2022-02-28 | 2022-02-25 | EWTX | ROOT JONATHAN D | Dir | J - Other | — | -3.47M | 0 | -100% | — |
| D | 2022-01-25 | 2022-01-21 | EWTX | MOORE JOHN R | GC | M - OptEx | $0.71 | +5,400 | 12.4K | +78% | +$3,834 |
| D | 2021-12-30 | 2021-12-28 | EWTX | MOORE JOHN R | GC | M - OptEx | $0.71 | +5,400 | 6,962 | +346% | +$3,834 |
| DM | 2021-12-01 | 2021-11-30 | EWTX | CSO, Dir | M - OptEx | $0.2191 | +172.6K | 172.6K | New | +$37.8K | |
| M | 2021-11-17 | 2021-11-15 | EWTX | Russell Alan J | CSO, Dir | S - Sale | $19.11 | -479 | 0 | -100% | -$9,155 |
| M | 2021-11-12 | 2021-11-09+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $19.91 | -69.7K | 40.6K | -63% | -$1.39M |
| M | 2021-11-08 | 2021-11-04+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $19.82 | -29.5K | 92.3K | -24% | -$583.7K |
| M | 2021-11-03 | 2021-11-01+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $17.88 | -44.2K | 99.7K | -31% | -$789.9K |
| M | 2021-10-18 | 2021-10-14+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $18.17 | -7,182 | 143.8K | -5% | -$130.5K |
| 2021-10-13 | 2021-10-11 | EWTX | Russell Alan J | CSO, Dir | S - Sale | $18.02 | -1,270 | 151.0K | -0.8% | -$22.9K | |
| M | 2021-10-08 | 2021-10-06+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $18.39 | -21.0K | 158.2K | -12% | -$386.7K |
| M | 2021-10-05 | 2021-10-01+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $18.24 | -5,778 | 178.7K | -3% | -$105.4K |
| M | 2021-09-30 | 2021-09-28+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $17.10 | -26.5K | 190.9K | -12% | -$452.5K |
| M | 2021-09-27 | 2021-09-23+ | EWTX | Russell Alan J | CSO, Dir | S - Sale | $18.30 | -58.5K | 237.3K | -20% | -$1.07M |
Purchase Sale Sale after option exercise All abbreviations